Peer-reviewedCC BY-NC-NDLiver international : official journal of the International Association for the Study of the Liver
Safety, Tolerability and Antiviral Activity of GST‐HG131 in Chronic Hepatitis B: A Randomized, Double‐Blind Phase IIa Study
5 affiliations
- 1The Fifth Medical Center of Chinese PLA General Hospital
- 2Fujian Akeylink Biotechnology Co. Ltd.
- 3Mengchao Hepatobiliary Hospital of Fujian Medical University
- 4The Second Affiliated Hospital of Chongqing Medical University
- 5Nanfang Hospital Nanfang Medical University
Related
- High Frequency of Circulating IL-4R+SELL+ Naïve B Cells Is Associated with Functional Cure in Chronic Hepatitis B Patients Receiving Antiviral Treatment
- Complete remission of minimal change disease after antiviral monotherapy in a patient with immune-active chronic hepatitis B: A case report.
- MDL-001: An Oral, Direct-Acting Broad-Spectrum Antiviral for Influenza-like Illness (ILI) and Chronic Hepatitis In Vivo
- A Randomized, Double‐Blind, Placebo‐Controlled Study of the PD‐1 Inhibitor Cetrelimab in Chronic Hepatitis B
- Twelve-Month Efficacy and Visual Tolerability of MyoPi Spectacle Lenses in Childhood Myopia : A Randomized Clinical Trial
BibTeX
@article{guo2026safety,
title = {{Safety, Tolerability and Antiviral Activity of GST‐HG131 in Chronic Hepatitis B: A Randomized, Double‐Blind Phase IIa Study}},
author = {Yuming Guo and Zhe Xu and Yuanyuan Li and John Mao and Tianxiang Zhang and Yonggang Li and Fanping Meng and Junliang Fu and Dong Ji and Yingjie Ji and Yongqian Cheng and Min Zhang and Xin Zhang and Ying Sun and Zuxiong Huang and Dachuan Cai and Wenqiang Wu and Wenhao Yan and Xiuping Yan and Guoping Li and Jinlin Hou and George Zhang and Fu‐Sheng Wang},
journal = {Liver international : official journal of the International Association for the Study of the Liver},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13659021},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Safety, Tolerability and Antiviral Activity of GST‐HG131 in Chronic Hepatitis B: A Randomized, Double‐Blind Phase IIa Study
AU - Yuming Guo
AU - Zhe Xu
AU - Yuanyuan Li
AU - John Mao
AU - Tianxiang Zhang
AU - Yonggang Li
AU - Fanping Meng
AU - Junliang Fu
AU - Dong Ji
AU - Yingjie Ji
AU - Yongqian Cheng
AU - Min Zhang
AU - Xin Zhang
AU - Ying Sun
AU - Zuxiong Huang
AU - Dachuan Cai
AU - Wenqiang Wu
AU - Wenhao Yan
AU - Xiuping Yan
AU - Guoping Li
AU - Jinlin Hou
AU - George Zhang
AU - Fu‐Sheng Wang
PY - 2026
DA - 2026/10/12
JO - Liver international : official journal of the International Association for the Study of the Liver
UR - https://europepmc.org/article/PMC/PMC13659021
SN - 1478-3223
SN - 1478-3231
ER -